Gout clinical trials at UCSF
1 in progress, 0 open to eligible people
Gout: Allopurinol vs. Febuxostat
Sorry, in progress, not accepting new patients
This trial will compare two effective therapies, allopurinol and febuxostat, to lower serum uric acid and therefore prevent further gout attacks. These therapies have never been compared at appropriate doses. Further, they will be studied in patients with kidney disease for the first time.
San Francisco, California and other locations
Last updated: